Jim Cramer's Stop Trading June 4
Celgene (NasdaqGS: CELG - News), Onyx Pharmaceuticals (NasdaqGM: ONXX - News): Although Celgene's stock performance has been like a "tree falling in the woods," Cramer would buy the stock because of Revlimid, its cancer drug. The stock is up 50% since last year and is "ready to roll again." He also likes ONXX which was ignored at American Society of Clinical Oncology conference, in spite of its liver cancer drug. Cramer says its decline is a "mistake."
Wal-Mart (NYSE: WMT - News): In spite of WMT's 3% gain for a second day, Cramer would not wait for it to decline, but believes the stock could reach $61 next year from $50.
Sirius Satellite Radio (NasdaqGS: SIRI - News): A Bear Stearns analyst's upgrade of SIRI was a "big call," and Cramer would consider buying the stock on the analyst's credibility. However, the call was "not working" with SIRI down 3 cents at $2.85, but he predicts SIRI will reach the estimate of $4.
Published by SeekingAlpha
Wal-Mart (NYSE: WMT - News): In spite of WMT's 3% gain for a second day, Cramer would not wait for it to decline, but believes the stock could reach $61 next year from $50.
Sirius Satellite Radio (NasdaqGS: SIRI - News): A Bear Stearns analyst's upgrade of SIRI was a "big call," and Cramer would consider buying the stock on the analyst's credibility. However, the call was "not working" with SIRI down 3 cents at $2.85, but he predicts SIRI will reach the estimate of $4.
Published by SeekingAlpha
Labels: CELG, Jim Cramer, ONXX, SIRI, Stop Trading, WMT
posted by Stock Administrator @ 8:41 AM
0 Comments:
Post a Comment
<< Home